Omega Diagnostics Gp - Notice of Results

Cambridge Nutritional Sciences

27/07/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230727:nRSa2991Ha&default-theme=true

RNS Number : 2991H  Omega Diagnostics Group PLC  27 July 2023

 

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

 

Notice of Final Results

Investor Presentation

 

Omega (AIM: ODX), the specialist medical diagnostics company focused on
industry-leading Health & Nutrition products, confirms it will issue its
final results for the year ended 31 March 2023 on Thursday 3 August 2023.

 

Analyst briefing

A briefing for analysts will take place in London on Thursday 3 August 2023 at
9:30 BST. To register and for more details please contact Walbrook PR on
omega@walbrookpr.com (mailto:omega@walbrookpr.com) .

 

Investor presentation

Jag Grewal, CEO and Chris Lea, CFO will provide a live presentation relating
to the Final Results via the Investor Meet Company platform on Thursday 3
August 2023 at 16:30 BST.

 

The presentation is open to all existing and potential shareholders. Questions
can be submitted pre-event via your Investor Meet Company dashboard up until
9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Omega
Diagnostics Group plc via:

 

https://www.investormeetcompany.com/omega-diagnostics-group-plc/register-investor
(https://www.investormeetcompany.com/omega-diagnostics-group-plc/register-investor)
 

 

Investors who already follow Omega Diagnostics Group plc on the Investor
Meet Company platform will automatically be invited.

 

Contacts:

 

 Omega Diagnostics Group PLC                                                                           www.omegadx.com (http://www.omegadx.com)
 Jag Grewal, Chief Executive                                                                           via Walbrook PR
 Officer
 Chris Lea, Chief Financial Officer

 finnCap                                                                                               Tel: 020 7220 0500
 Ltd
 Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)
 Alice Lane/Charlotte Sutcliffe (ECM)

 Walbrook PR Limited                                Tel: 020 7933 8780 or omega@walbrookpr.com (mailto:omega@walbrookpr.com)
 Lianne Applegarth                                                                                     Mob: 07584 391 303
 Sam Allen                                                                                             Mob: 07502 558 258

 

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on
promoting a personalised and functional approach to health and nutrition.

 

www.omegadx.com (http://www.omegadx.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORFZGZNZVGGFZM